Still much to do, and I'm incredibly grateful for the support and energy of everyone who is trying to help us regain our globally-leading position.
Pleased to see HM Govt is keeping up momentum on my Clinical Trials Review, including the ‘double-doubling’ ambition.
MHRA is performing much better, moving to a national approach to contracting and costing, and the number of industry-sponsored trials in the UK is growing again.